Dr Kobra Karimkhani, MD | |
938 Beaver Grade Rd, Moon Township, PA 15108-2716 | |
(412) 262-3230 | |
(412) 262-1451 |
Full Name | Dr Kobra Karimkhani |
---|---|
Gender | Female |
Speciality | Obstetrics & Gynecology |
Location | 938 Beaver Grade Rd, Moon Township, Pennsylvania |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1922044932 | NPI | - | NPPES |
000725240 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | MD033296L (Pennsylvania) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Kobra Karimkhani, MD 938 Beaver Grade Rd, Moon Township, PA 15108-2716 Ph: (412) 262-3230 | Dr Kobra Karimkhani, MD 938 Beaver Grade Rd, Moon Township, PA 15108-2716 Ph: (412) 262-3230 |
News Archive
Patients with early stage lung cancer live longer when they receive a lobectomy- the most common type of operation for the disease- rather than a less extensive operation or radiation treatment, according to a study published online today in The Annals of Thoracic Surgery.
A translational, multicenter study carried out by research groups of the Bellvitge Biomedical Research Institute, San Juan de Dios Hospital, the University of Barcelona, Clinic Hospital, the University of Vic, Santa Creu i Sant Pau Hospital and the thematic area of Rare Diseases, has unveiled the potential of D-serine - a dietary supplement - to improve the neuronal function of a patient with a mutation of the glutamate receptors associated to atypical Rett syndrome with severe encephalopathy.
A new study in the journal PLoS ONE finds that people use the same brain regions to produce and understand intonation in speech.
Gilead Sciences, Inc. today announced receipt of a Paragraph IV Certification Notice Letter advising that Sigmapharm Laboratories, LLC submitted an Abbreviated New Drug Application (ANDA) to the U.S. Food and Drug Administration (FDA) requesting permission to manufacture and market a generic version of Hepsera® (adefovir dipivoxil).
› Verified 3 days ago